Psoriatic arthritis (PsA) is a chronic inflammatory ... particularly with regard to biologically targeted treatments, such as the TNF inhibitors (TNFi). However, treatment regimens used in PsA ...

In the phase 4 FOREMOST trial, treatment with apremilast improved both clinical and patient-reported outcomes at week 16 among patients with early oligoarticular PsA.

Targeted therapies for PsA are effective for reducing the use of symptomatic treatments, sick leave, and rates of hospitalization.

PRNewswire Ahmedabad Gujarat [India] October 14 Accord BioPharma Inc the US specialty division of Intas Pharmaceuticals Ltd ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

Individuals with self-reported moderate to severe psoriatic arthritis (PsA) face a higher disease burden, particularly among ...

Psoriatic arthritis surgery could involve removing damaged tissue or bone or replacing a joint with severe damage. Learn more here.

Alex Thompson CFA, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Oruka Therapeutics (ORKA). Alex Thompson CFA has given ...

Essentially, he was asking what makes RA different from the type of arthritis that you usually hear about: osteoarthritis.

Discover how to reduce inflammation and alleviate symptoms with strategies such as optimizing sleep environment, stretching, ...

Symptoms of psoriatic arthritis are similar to rheumatoid arthritis and include, pain, swelling and stiffness in one or more ...

Plaque psoriasis, the most common form of psoriasis (about 90 per cent of cases), is a chronic inflammatory autoimmune ...